共 107 条
[1]
Siegel R(2013)Cancer statistics, 2013 CA: A Cancer Journal for Clinicians 63 11-30
[2]
Naishadham D(2007)The non-Hodgkin lymphomas: a review of the epidemiologic literature Int J Cancer 120 1-39
[3]
Jemal A(2005)B cell non-Hodgkin’s lymphoma: rituximab safety experience Arthritis Res Ther 7 S19-S25
[4]
Alexander DD(1994)CD20: a regulator of cell-cycle progression of B lymphocytes Immunol Today 15 450-454
[5]
Mink PJ(2008)CD20 homo-oligomers physically associate with the B cell antigen receptor. Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins J Biol Chem 283 18545-18552
[6]
Adami HO(2013)TGF-β-induced apoptosis of B-cell lymphoma Ramos cells through reduction of MS4A1/CD20 Oncogene 32 2096-2106
[7]
Mohrbacher A(1988)Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains EMBO J 7 711-717
[8]
Tedder TF(1987)Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas Blood 69 584-591
[9]
Engel P(1984)Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation Blood 63 1424-1433
[10]
Polyak MJ(2002)Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia Leuk Lymphoma 43 149-151